Showing results (91-100 of 206) with videos related to
Sort By:
Pageof 21
Science (New York, N.Y.)|October 26, 1990
Protection of mice against the Lyme disease agent by immunizing with recombinant OspAE Fikrig, S W Barthold, F S Kantor, et al.The Journal of Infectious Diseases|December 26, 2001
Thrombocytopenia in a mouse model of human granulocytic ehrlichiosisD L Borjesson, S I Simon, F Tablin, et al.Infection and Immunity|January 10, 1998
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathwayM C Shanafelt, I Kang, S W Barthold, et al.Parasitology Today (Personal Ed.)|April 1, 1993
Protective immunity in lyme borreliosisE Fikrig, F S Kantor, S W Barthold, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 2, 2012
Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infectionChristine J Hastey, Rebecca A Elsner, Stephen W Barthold, et al.The Journal of Clinical Investigation|February 15, 1996
Effect of anti-interleukin 12 treatment on murine lyme borreliosisJ Anguita, D H Persing, M Rincon, et al.Archives of Virology|January 1, 1992
Responses of mice to murine coronavirus immunizationA L Smith, M S de Souza, D Finzi, et al.Journal of Wildlife Diseases|April 1, 1994
Experimental Borrelia burgdorferi infection in Peromyscus leucopusK D Moody, G A Terwilliger, G M Hansen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1997
Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferiS W Barthold, S Feng, L K Bockenstedt, et al.Antimicrobial Agents and Chemotherapy|March 5, 2008
Persistence of Borrelia burgdorferi following antibiotic treatment in miceEmir Hodzic, Sunlian Feng, Kevin Holden, et al.Pageof 21